Comparison of two estradiol transdermal systems (Oesclim® 50 and estraderm TTS® 50). II. Local skin tolerability
- 30 November 1996
- Vol. 25 (3) , 175-185
- https://doi.org/10.1016/s0378-5122(96)01074-2
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Efficacy and tolerability of Menorest® 50 compared with estraderm® TTS 50 in the treatment of postmenopausal symptoms. A randomized, multicenter, parallel group studyMaturitas, 1995
- Comparative metabolic study of percutaneous versus oral micronized 17β-oestradiol in replacement therapyMaturitas, 1989
- Contact dermatitis to transdermal estradiol systemJournal of the American Academy of Dermatology, 1989
- Biological Effects of Estradiol-17β in Postmenopausal Women: Oral Versus percutaneous AdministrationJournal of Clinical Endocrinology & Metabolism, 1986
- Pharmacokinetics and pharmacodynamics of transdermal dosage forms of 17β-estradiol: Comparison with conventional oral estrogens used for hormone replacementAmerican Journal of Obstetrics and Gynecology, 1985
- Efficacy, acceptability, and metabolic effects of transdermal estradiol in the management of postmenopausal womenAmerican Journal of Obstetrics and Gynecology, 1985
- A double-blind comparative study of Estraderm and Premarin in the amelioration of postmenopausal symptomsAmerican Journal of Obstetrics and Gynecology, 1985